Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001574080 | SCV001800831 | uncertain significance | not provided | 2024-05-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 21520338, 31554319, 9590290) |
Labcorp Genetics |
RCV001574080 | SCV004270537 | benign | not provided | 2023-04-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039426 | SCV004963845 | uncertain significance | Inborn genetic diseases | 2024-01-08 | criteria provided, single submitter | clinical testing | The c.3704A>G (p.N1235S) alteration is located in exon 11 (coding exon 11) of the TECTA gene. This alteration results from a A to G substitution at nucleotide position 3704, causing the asparagine (N) at amino acid position 1235 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |